Corticotropin-Releasing Factor (CRF) Sensitization of Ethanol Withdrawal-Induced Anxiety-Like Behavior is Brain Site Specific and Mediated by CRF-1 Receptors: Relation to Stress-Induced Sensitization
Authors:
- David H. OverstreetDODavid H. Overstreet
- Darin J. KnappDKDarin J. Knapp
- Robert AngelRARobert Angel
- Tiffany A. WillsTWTiffany A. Wills
- Montserrat NavarroMNMontserrat Navarro
- Jean RivierJRJean Rivier
- Wylie ValeWVWylie Vale
- George R. BreeseGBGeorge R. Breese
- 1 January 2010
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 332 (1) , 298-307
Abstract
In abstinent alcoholics, stress induces negative affect—a response linked to craving and relapse. In rats, repeated stresses at weekly intervals before 5-day ethanol diet sensitize withdrawal-induced anxiety-like behavior (“anxiety”) that is blocked by a corticotrophin-releasing factor 1 (CRF-1)-receptor antagonist. Current experiments were performed to identify brain sites that support CRF involvement in stress sensitization of ethanol withdrawal-induced anxiety-like behavior. First, different doses of CRF microinjected weekly into the central amygdala (CeA) before ethanol exposure produced a dose-related sensitization of anxiety during ethanol withdrawal. Subsequently, CRF microinjection into the basolateral amygdala, dorsal raphe nucleus (DRN), or dorsal bed nucleus of the stria terminalis (d-BNST) also sensitized ethanol withdrawal-induced anxiety. In contrast, sensitization of ethanol withdrawal-induced anxiety was not observed after weekly CRF administration into the ventral-BNST, CA1-hippocampal region, or hypothalamic-paraventricular nucleus. Then, experiments documented the CRF receptor subtype responsible for CRF and stress sensitization of withdrawal-induced anxiety. Systemic administration of a CRF-1 receptor antagonist before CRF microinjection into the CeA, DRN, or d-BNST prevented CRF-induced sensitization of anxiety during ethanol withdrawal. Furthermore, repeated microinjections of urocortin-3, a CRF-2 receptor agonist, into the CRF-positive sites did not sensitize anxiety after withdrawal from ethanol. Finally, microinjection of a CRF-1 receptor antagonist into the CeA, DRN, or d-BNST before stress blocked sensitization of anxiety-like behavior induced by the repeated stress/ethanol withdrawal protocol. These results indicate that CRF released by stress acts on CRF-1 receptors within specific brain regions to produce a cumulative adaptation that sensitizes anxiety-like behavior during withdrawal from chronic ethanol exposure.Keywords
This publication has 53 references indexed in Scilit:
- Chronic Stress, Drug Use, and Vulnerability to AddictionAnnals of the New York Academy of Sciences, 2008
- A Role for Brain Stress Systems in AddictionNeuron, 2008
- Enhanced Negative Emotion and Alcohol Craving, and Altered Physiological Responses Following Stress and Cue Exposure in Alcohol Dependent IndividualsNeuropsychopharmacology, 2008
- Repeated Stimulation of CRF Receptors in the BNST of Rats Selectively Induces Social but not Panic-Like AnxietyNeuropsychopharmacology, 2008
- The Amygdala Regulates the Antianxiety Sensitization Effect of Flumazenil During Repeated Chronic Ethanol or Repeated StressAlcohol, Clinical and Experimental Research, 2007
- A key role for corticotropin-releasing factor in alcohol dependenceTrends in Neurosciences, 2007
- Drug Challenges Reveal Differences in Mediation of Stress Facilitation of Voluntary Alcohol Drinking and Withdrawal‐Induced Anxiety in Alcohol‐Preferring P RatsAlcohol, Clinical and Experimental Research, 2007
- Reduction in repeated ethanol-withdrawal-induced anxiety-like behavior by site-selective injections of 5-HT1A and 5-HT2C ligandsPsychopharmacology, 2006
- Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the ratPsychopharmacology, 2002
- Organization of Ovine Corticotropin-Releasing Factor Immunoreactive Cells and Fibers in the Rat Brain: An Immunohistochemical StudyNeuroendocrinology, 1983